Literature DB >> 22176347

High fat diet induced hepatic steatosis and insulin resistance: Role of dysregulated ceramide metabolism.

Lisa Longato1, Ming Tong, Jack R Wands, Suzanne M de la Monte.   

Abstract

AIM: Non-alcoholic fatty liver disease (NAFLD) is an insulin resistance disease that can progress to cirrhosis and liver failure. We hypothesized that in NAFLD, insulin resistance dysregulates lipid metabolism, increasing production of cytotoxic lipids including ceramides, which exacerbate hepatic insulin resistance and injury.
METHODS: Long Evans rats were pair-fed low (LFD) or high (HFD) fat diets for 8 weeks. Livers were used to measure lipids, gene expression, insulin receptor binding, integrity of insulin signaling, and pro-inflammatory cytokines. In vitro experiments characterized effects of ceramides on Huh7 cell viability, mitochondrial function, and insulin signaling.
RESULTS: High fat diet feeding caused NAFLD with peripheral and hepatic insulin resistance, increased hepatic expression of pro-ceramide genes, sphingomyelinase activity, and lipid peroxidation, and increased serum ceramide. Ceramide treatment impaired Huh7 cell viability, mitochondrial function, and insulin signaling.
CONCLUSIONS: Increased hepatic ceramide generation and release may mediate both hepatic and peripheral insulin resistance in NAFLD.
© 2011 The Japan Society of Hepatology.

Entities:  

Year:  2011        PMID: 22176347      PMCID: PMC4096625          DOI: 10.1111/j.1872-034X.2011.00934.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  77 in total

1.  Gene expression in human NAFLD.

Authors:  Dario Greco; Anna Kotronen; Jukka Westerbacka; Oscar Puig; Perttu Arkkila; Tuula Kiviluoto; Saara Laitinen; Maria Kolak; Rachel M Fisher; Anders Hamsten; Petri Auvinen; Hannele Yki-Järvinen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-04-03       Impact factor: 4.052

2.  Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.

Authors:  M Chiara Cantarini; Suzanne M de la Monte; Maoyin Pang; Ming Tong; Antonia D'Errico; Franco Trevisani; Jack R Wands
Journal:  Hepatology       Date:  2006-08       Impact factor: 17.425

Review 3.  The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity.

Authors:  E W Kraegen; G J Cooney; J M Ye; A L Thompson; S M Furler
Journal:  Exp Clin Endocrinol Diabetes       Date:  2001       Impact factor: 2.949

4.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells.

Authors:  F Tremblay; A Marette
Journal:  J Biol Chem       Date:  2001-08-09       Impact factor: 5.157

Review 5.  Mechanisms of disease progression in nonalcoholic fatty liver disease.

Authors:  Janice Jou; Steve S Choi; Anna Mae Diehl
Journal:  Semin Liver Dis       Date:  2008-10-27       Impact factor: 6.115

6.  Protection from high fat diet-induced increase in ceramide in mice lacking plasminogen activator inhibitor 1.

Authors:  Charmi Shah; Guang Yang; Ian Lee; Jacek Bielawski; Yusuf A Hannun; Fahumiya Samad
Journal:  J Biol Chem       Date:  2008-03-22       Impact factor: 5.157

7.  Mechanisms of ceramide-mediated neurodegeneration.

Authors:  Ming Tong; Suzanne M de la Monte
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

8.  Regulation of insulin action by ceramide: dual mechanisms linking ceramide accumulation to the inhibition of Akt/protein kinase B.

Authors:  Suzanne Stratford; Kyle L Hoehn; Feng Liu; Scott A Summers
Journal:  J Biol Chem       Date:  2004-06-25       Impact factor: 5.157

Review 9.  Free fatty acids and skeletal muscle insulin resistance.

Authors:  Edward W Kraegen; Gregory J Cooney
Journal:  Curr Opin Lipidol       Date:  2008-06       Impact factor: 4.776

Review 10.  Sphingolipids: players in the pathology of metabolic disease.

Authors:  L Ashley Cowart
Journal:  Trends Endocrinol Metab       Date:  2008-11-13       Impact factor: 12.015

View more
  36 in total

1.  Withaferin A Improves Nonalcoholic Steatohepatitis in Mice.

Authors:  Daxesh P Patel; Tingting Yan; Donghwan Kim; Henrique B Dias; Kristopher W Krausz; Shioko Kimura; Frank J Gonzalez
Journal:  J Pharmacol Exp Ther       Date:  2019-08-16       Impact factor: 4.030

2.  Clostridium difficile heterogeneously impacts intestinal community architecture but drives stable metabolome responses.

Authors:  David Rojo; María J Gosalbes; Rafaela Ferrari; Ana E Pérez-Cobas; Ester Hernández; Rosa Oltra; Javier Buesa; Amparo Latorre; Coral Barbas; Manuel Ferrer; Andrés Moya
Journal:  ISME J       Date:  2015-03-10       Impact factor: 10.302

3.  Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.

Authors:  Resat Cinar; Grzegorz Godlewski; Jie Liu; Joseph Tam; Tony Jourdan; Bani Mukhopadhyay; Judith Harvey-White; George Kunos
Journal:  Hepatology       Date:  2013-11-18       Impact factor: 17.425

4.  Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis.

Authors:  Teresa Ramirez; Lisa Longato; Miroslav Dostalek; Ming Tong; Jack R Wands; Suzanne M de la Monte
Journal:  Alcohol Alcohol       Date:  2012-09-20       Impact factor: 2.826

5.  Liver-specific knockdown of long-chain acyl-CoA synthetase 4 reveals its key role in VLDL-TG metabolism and phospholipid synthesis in mice fed a high-fat diet.

Authors:  Amar B Singh; Chin Fung K Kan; Fredric B Kraemer; Raymond A Sobel; Jingwen Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-02-05       Impact factor: 4.310

Review 6.  Dietary habits and behaviors associated with nonalcoholic fatty liver disease.

Authors:  Kenichiro Yasutake; Motoyuki Kohjima; Kazuhiro Kotoh; Manabu Nakashima; Makoto Nakamuta; Munechika Enjoji
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

7.  CD36 genetic variation, fat intake and liver fibrosis in chronic hepatitis C virus infection.

Authors:  Omar Ramos-Lopez; Sonia Roman; Erika Martinez-Lopez; Nora A Fierro; Karina Gonzalez-Aldaco; Alexis Jose-Abrego; Arturo Panduro
Journal:  World J Hepatol       Date:  2016-09-08

Review 8.  Defect of insulin signal in peripheral tissues: Important role of ceramide.

Authors:  Rima Hage Hassan; Olivier Bourron; Eric Hajduch
Journal:  World J Diabetes       Date:  2014-06-15

Review 9.  Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.

Authors:  Manoela Mota; Bubu A Banini; Sophie C Cazanave; Arun J Sanyal
Journal:  Metabolism       Date:  2016-03-03       Impact factor: 8.694

10.  Chronic alcohol-induced hepatic insulin resistance and endoplasmic reticulum stress ameliorated by peroxisome-proliferator activated receptor-δ agonist treatment.

Authors:  Teresa Ramirez; Ming Tong; William Cy Chen; Quynh-Giao Nguyen; Jack R Wands; Suzanne M de la Monte
Journal:  J Gastroenterol Hepatol       Date:  2013-01       Impact factor: 4.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.